Medicare Enrolled

Dr. Sharique Ansari, M.D., MPH

Neurology · Fort Worth, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4525 HERITAGE TRACE PKWY STE 117, Fort Worth, TX 76244
8172676290
In practice since 2008 (17 years)
NPI: 1891944617 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ansari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ansari? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ansari

Dr. Sharique Ansari is a neurology in Fort Worth, TX, with 17 years in practice. Based on federal Medicare data, Dr. Ansari performed 1,243 Medicare services across 940 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ansari received a total of $78,412 from 96 pharmaceutical and/or device companies across 1572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ansari is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 26% volume in TX$ $78,412 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,243
Medicare services
Top 26% in TX for neurology
940
Unique beneficiaries
$99
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Needle measurement of electrical activity in arm or leg muscles, complete study386$77$150
Office visit, established patient (30-39 min)352$89$195
New patient office visit (45-59 min)97$118$260
Office visit, established patient (20-29 min)77$62$145
Initial hospital admission, high complexity72$129$297
Nerve conduction, 9-10 studies71$162$323
Nerve conduction, 11-12 studies69$181$395
Hospital follow-up visit, moderate complexity36$61$105
Nerve conduction, 13 or more studies32$219$436
Telephone medical discussion with physician, 11-20 minutes20$56$137
Telephone medical discussion with physician, 5-10 minutes16$26$85
Nerve conduction, 7-8 studies15$138$266
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$78,412
Total received (2018-2024)
Avg $11,202/year across 7 years
Top 8% in TX for neurology
96
Companies
1,572
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$57,730 (73.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,683 (26.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40,880
2023
$7,982
2022
$11,327
2021
$6,578
2020
$5,382
2019
$4,398
2018
$1,865

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$28,486
UCB, Inc.
$26,697
Akcea Therapeutics, Inc.
$2,106
CSL Behring
$1,856
ABBVIE INC.
$1,513
Teva Pharmaceuticals USA, Inc.
$1,405
Biogen, Inc.
$1,226
Novartis Pharmaceuticals Corporation
$1,177
AbbVie Inc.
$904
EMD Serono, Inc.
$846
Grifols USA, LLC
$790
Allergan, Inc.
$750
Amgen Inc.
$596
Genentech USA, Inc.
$553
ACADIA Pharmaceuticals Inc
$518
Alnylam Pharmaceuticals Inc.
$504
Lundbeck LLC
$491
GENZYME CORPORATION
$438
Allergan Inc.
$436
Lilly USA, LLC
$407
Merz Pharmaceuticals, LLC
$398
Biohaven Pharmaceuticals, Inc.
$369
PFIZER INC.
$325
Neurocrine Biosciences, Inc.
$268
Biohaven Pharmaceutical Holding Company Ltd.
$263
ARGENX US, INC.
$257
Eisai Inc.
$248
Kyowa Kirin, Inc.
$237
Amylyx Pharmaceuticals, Inc.
$219
Amneal Pharmaceuticals LLC
$215
Takeda Pharmaceuticals U.S.A., Inc.
$193
MITSUBISHI TANABE PHARMA AMERICA, INC.
$181
Upsher-Smith Laboratories LLC
$176
US WorldMeds, LLC
$175
UPSHER-SMITH LABORATORIES LLC
$161
Ipsen Biopharmaceuticals, Inc
$154
Octapharma USA, Inc.
$140
IMPEL PHARMACEUTICALS INC.
$133
Mitsubishi Tanabe Pharma America, Inc.
$128
Sunovion Pharmaceuticals Inc.
$111
Adamas Pharmaceuticals, Inc.
$111
Avanir Pharmaceuticals, Inc.
$102
Promius Pharma LLC
$97
SK Life Science, Inc.
$94
Merz North America, Inc.
$93
JAZZ PHARMACEUTICALS INC.
$89
Celgene Corporation
$88
MERZ NORTH AMERICA, INC.
$86
Acorda Therapeutics, Inc
$86
GE HealthCare
$84
Sumitomo Pharma America, Inc.
$81
ARBOR PHARMACEUTICALS, INC.
$75
AbbVie, Inc.
$73
Janssen Pharmaceuticals, Inc
$70
GE HEALTHCARE
$67
CATALYST PHARMACEUTICALS, INC.
$64
TG THERAPEUTICS, INC.
$62
Assertio Therapeutics, Inc.
$56
AstraZeneca Pharmaceuticals LP
$49
Otsuka America Pharmaceutical, Inc.
$48
Supernus Pharmaceuticals, Inc.
$47
Currax Pharmaceuticals LLC
$40
Arbor Pharmaceuticals, Inc.
$39
Exeltis, USA Inc.
$37
Boston Scientific Corporation
$37
Avion Pharmaceuticals
$34
Medtronic, Inc.
$32
Sandoz Inc.
$31
MDD US Operations, LLC
$30
Mallinckrodt LLC
$29
BANNER LIFE SCIENCES, LLC
$25
Greenwich Biosciences, Inc.
$24
Aucta Pharmaceuticals, Inc.
$23
TG Therapeutics, Inc.
$23
BOSTON SCIENTIFIC CORPORATION
$20
Banner Life Sciences, LLC
$20
LivaNova USA, Inc.
$20
Catalyst Pharmaceuticals, Inc.
$19
Scilex Pharmaceuticals Inc.
$18
Nevro Corp.
$17
Bausch Health US, LLC
$16
Jazz Pharmaceuticals Inc.
$16
Saol Therapeutics Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
SCILEX PHARMACEUTICALS INC.
$14
Aprecia Pharmaceuticals, LLC
$14
IDORSIA PHARMACEUTICALS US INC
$14
Corium, LLC
$14
HARMONY BIOSCIENCES LLC
$14
Almatica Pharma LLC
$14
ANI Pharmaceuticals, Inc.
$13
Vertical Pharmaceuticals, LLC
$13
Horizon Therapeutics plc
$13
Mallinckrodt Enterprises LLC
$13
Strongbridge US INC.
$12
Philips Electronics North America Corporation
$12
Top 3 companies account for 73.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX - NEUROLOGY · BOTOX - SPASTICITY · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CAMBIA · CONTRAVE · COPAXONE · CREXONT · Cambia · DIVIGEL · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · EVENITY · Epidiolex · Eprontia · FABRY-DISEASE · FIRDAPSE · Fycompa · GAMMAGARD · GAUCHER-DISEASE · GILENYA · GOCOVRI · GamaSTAN · Gamunex-C · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · QALSODY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · Senza · Soliris · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WaveWriter Alpha Prime 16 · Wellcentive Undiv · XEOMIN · XYREM · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neurology in TX.

Equivalent to $6,308 per 100 Medicare services performed
Looking for a neurology in Fort Worth?
Compare neurologys in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
91
Per 100K population
4.3
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL ALLIANCE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ansari is a clinical cardiology specialist, with above-average Medicare volume (top 26% in TX), and high industry engagement (speaking/promotional, top 8%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ansari experienced with needle measurement of electrical activity in arm or leg muscles, complete study?
Based on Medicare claims data, Dr. Ansari performed 386 needle measurement of electrical activity in arm or leg muscles, complete study services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ansari receive payments from pharmaceutical companies?
Yes. Dr. Ansari received a total of $78,412 from 96 companies across 1,572 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ansari's costs compare to other neurologys in Fort Worth?
Dr. Ansari's average Medicare payment per service is $99. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ansari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →